Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.64B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$928M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$804M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$765M |
Top Sells
| 1 |
CRH
CRH
|
+$771M |
| 2 |
Bank of America
BAC
|
+$711M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$536M |
| 4 |
NVIDIA
NVDA
|
+$481M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$417M |
Sector Composition
| 1 | Technology | 29.49% |
| 2 | Financials | 11.51% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Healthcare | 10.02% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Atomera
ATOM
$103M
| $215K | ﹤0.01% |
30,717
+27,056
| +739% | +$189K |
|
3352
Future Fuel
FF
$172M
| $215K | ﹤0.01% |
35,330
-20,379
| -37% | -$124K |
|
3353
Five Point Holdings
FPH
$418M
| $215K | ﹤0.01% |
70,087
| – | – |
|
3354
Fortuna Silver Mines
FSM
$2.59B
| $215K | ﹤0.01% |
55,658
+2,465
| +5% | +$9.52K |
|
3355
Tenaya Therapeutics
TNYA
$209M
| $215K | ﹤0.01% |
66,395
-183,163
| -73% | -$593K |
|
3356
ClearPoint Neuro
CLPT
$315M
| $214K | ﹤0.01% |
31,524
+27,417
| +668% | +$186K |
|
3357
Vanguard Mid-Cap ETF
VO
$88.6B
| $213K | ﹤0.01% |
917
| – | – |
|
3358
Cenovus Energy
CVE
$30.4B
| $212K | ﹤0.01% |
12,693
-83,818
| -87% | -$1.4M |
|
3359
Foghorn Therapeutics
FHTX
$298M
| $212K | ﹤0.01% |
32,904
+29,341
| +823% | +$189K |
|
3360
PetMed Express
PETS
$58.5M
| $212K | ﹤0.01% |
28,081
+20,928
| +293% | +$158K |
|
3361
NACCO Industries
NC
$306M
| $211K | ﹤0.01% |
5,787
+5,019
| +654% | +$183K |
|
3362
Vanguard Small-Cap ETF
VB
$67.9B
| $211K | ﹤0.01% |
988
| – | – |
|
3363
Verrica Pharmaceuticals
VRCA
$46.7M
| $210K | ﹤0.01% |
2,864
+2,501
| +689% | +$183K |
|
3364
Butterfly Network
BFLY
$390M
| $209K | ﹤0.01% |
194,192
+129,806
| +202% | +$140K |
|
3365
FibroGen
FGEN
$50.3M
| $209K | ﹤0.01% |
9,417
+8,285
| +732% | +$184K |
|
3366
GrowGeneration
GRWG
$92.6M
| $209K | ﹤0.01% |
83,373
+73,402
| +736% | +$184K |
|
3367
Descartes Systems
DSGX
$9.19B
| $208K | ﹤0.01% |
2,465
+805
| +48% | +$67.9K |
|
3368
Lexeo Therapeutics
LXEO
$280M
| $208K | ﹤0.01% |
+15,517
| New | +$208K |
|
|
TUYA
3369
Tuya Inc
TUYA
$1.6B
| $208K | ﹤0.01% |
+90,646
| New | +$208K |
|
3370
Acacia Research
ACTG
$314M
| $206K | ﹤0.01% |
52,565
+43,825
| +501% | +$172K |
|
3371
Praxis Precision Medicines
PRAX
$830M
| $206K | ﹤0.01% |
+9,245
| New | +$206K |
|
3372
Stoke Therapeutics
STOK
$1.31B
| $206K | ﹤0.01% |
39,271
+30,831
| +365% | +$162K |
|
3373
Vanguard Total World Stock ETF
VT
$52.8B
| $206K | ﹤0.01% |
2,000
| – | – |
|
3374
CAVA Group
CAVA
$7.46B
| $204K | ﹤0.01% |
4,743
-6,239
| -57% | -$268K |
|
|
IGMS
3375
DELISTED
IGM Biosciences
IGMS
| $204K | ﹤0.01% |
24,570
+17,233
| +235% | +$143K |
|